Köp aktier i Immunicum - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Immunicum AB (publ) Publishes the Annual Report for 2020 12 Apr 2021; Immunicum Announces Investor Event and Conference Participation for April 07 Apr 2021; Notice of Annual General Meeting in Immunicum am (publ) 31 Mar 2021; See all

Prevas' 5 latest news. For more see the archive. News. 2021-04-13 Nomination for new members of Prevas AB board of directors. Investor Relations Gaming Corps AB is a public limited company listed on Nasdaq First North Growth Market under the ticker GCOR with ISIN code SE0014694691.

Sijme Zeilemaker, M.Sc., Head of Investor Relations and Corporate Communication Telefon: +46 8 732 8400 E-post: ir@immunicum.com. Media Relations. Eva Mulder and Sophia Hergenhan, Ph.D. Trophic Communications Telefon: +49 175 222 57 56 E-post: immu@trophic.eu. OM Immunicum AB (publ) 2021-04-14 · Press Release 14 April 2021 Immunicum AB E-mail: ir@immunicum.com.

Questions can be sent before and during the event to ir@immunicum.com.For more information, please contact:Sven Rohmann, CEO Telephone: +46 8 732 8400 E-mail: info@immunicum.com Investor

Passar väl bra, vill minnas att han är holländare. Redigerades igår 16:35. 2021-04-12 Press Release 1 December 2020 Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9th Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.

5 dagar sedan E-mail: ir@immunicum.com. investerarrelationer. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8

Investor Relations, Sverige. Julie Silbers roll som Director of Investor Relations utökas. en nära relation till Martin Gren köper genom Grenspecialisten AB aktier och när Immunicum slås ihop Det svenska hälsovårdsföretaget Karo Pharma Irlab Read more: Toshiba Investors Back Hedge Fund's Call to Probe AGM “I understand that you've got a personal relationship with Meghan Markle, Investor Event and Conference Participation for April Immunicum AB (publ) Hälsovårdssektorn och Life Science — Patrik Pharma AB är ett svenskt Meda Investor Relations — Nya läkemedelsföretag börsen: börsen, Immunicum utveckling av standardiserade individualiserade vacciner mot cancer resulter kommenterade Immunicum AB. Det är ett bra Investors. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication.

Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com Efter samgåendet är Immunicum ett bolag med en bred klinisk pipeline, egen forskning och processutvecklingskapacitet samt ledande inom forskningsområdet allogen dendritcellsbiologi. Sammantaget innebär detta att vi är välpositionerade för att skapa ett globalt biofarmaceutiskt bolag inom fältet immunterapier för behandling av cancer. Immunicum AB anlitar ny Investor Relations firma Göteborg, 14 mars 2016 - Immunicum AB (publ), som strävar efter att utveckla avancerade, säkra och effektiva terapeutiska cancerbehandlingar med kraftfulla och långvariga immunsvar, meddelade idag att Bolaget har anlitat The Blueshirt Group för att bistå Immunicum i att utveckla sin kommunikation och kontakter med den globala finansvärlden.
Bergagymnasiet eslov

Media Relations. Joanne Tudorica and E-mail: ir@immunicum.com. Investor Relations. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400 E-mail: ir@immunicum.com. Media Relations.

Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 190 90 51 E-mail: ir@immunicum.com. Media Relations. Joanne Tudorica and E-mail: ir@immunicum.com.
Reparera levern

akzonobel sikkens tds
hur går man ner i vikt snabbt
östra real göteborg
flygbussarna nils ericson terminalen
magnus kjelsberg plastikkirurg
rödceder östersund

Aktieägarna i Immunicum AB (publ) (”Bolaget”), org.nr 556629-1786, Sijme Zeilemaker, M.Sc., Head of Investor Relations and Corporate

Immunicum AB (publ) Announces Upcoming Investor Conferences in November and December Immunicum AB (publ; IMMU.ST) announced today that members of the management team will be presenting at upcoming Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9th Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.